OR WAIT null SECS
Solid state solutions provider Holodiag and fine chemical R&D provider Holochem join forces.
Holodiag, provider of solid state solutions, and Holochem, provider of chemical and process development services, have signed a strategic partnership, enabling both companies to supply customers with a full range of integrated fine chemical and API contract development and manufacturing services through all stages of the drug development lifecycle.
CRO Holodiag is known for its expertise in pharmaceutical solid state. Over the past years, the company has increasingly focussed on R&D, and the new partnership with Holochem is in line with this strategic direction. Holochem’s areas of expertise is in the chemical, process and analytical development phases of key intermediates and APIs.
Holodiag and Holochem support their pharmaceutical customers with fully integrated EP/USP/ICH compliant drug development and IMPD/IND/DMP regulatory support throughout the entire development process. Services remain available on a stand-alone basis. The partnership is also facilitated by the close geographic proximity of the companies, both based in Val-de-Reuil, one hour west of Paris, France.
Holodiag and Holochem will jointly exhibit at CPhI Worldwide (Oct. 24–26, 2017, Frankfurt).
Source: Holochem, Booth 41D50